文摘
A novel series of CHK1 inhibitors with a distinctive hinge binding mode, exemplified by 2-aryl-N-(2-(piperazin-1-yl)phenyl)thiazole-4-carboxamide, was discovered through high-throughput screening using the affinity selection鈥搈ass spectrometry (AS-MS)-based Automated Ligand Identification System (ALIS) platform. Structure-based ligand design and optimization led to significant improvements in potency to the single digit nanomolar range and hundred-fold selectivity against CDK2.
Keywords:
affinity selection鈭抦ass spectrometry (AS-MS); Automated Ligand Identification System (ALIS); CHK1 protein kinase; structure-based drug design; thiazole-4-carboxamide